4 results
To assess the impact of 10 intravenous infusions of 3 mg/kg CER-001 versus placebo, given at weekly intervals, on atherosclerotic plaque volume, as measured by coronary IVUS, when administered to subjects presenting with an ACS event.
Evaluate the effects of CER-001 - adminstered as iv infusion - on plaque size/burden in arteries, plaque inflammation in the artery wall and the rate of cholesterol transport in the body
To determine the safety and tolerability of L19-IL2 combined with SABR.
1. To investigate the feasibility of controlling an arm- and hand support system with EMG, voice or wink control.2. To assess usability of the arm and hand support controlled by EMG, voice or wink.3. To investigate the possibility to distinguish…